About Regenerative Medical Technology (RMTG) data
Data as of August 14, 2026.
Regenerative Medical Technology (RMTG) has 8.67K shares sold short as of the latest FINRA settlement report on August 14, 2026. Short interest has increased by 8,574.00% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.09 days (days to cover).
Recent RMTG short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Aug 14, 2026 | 8,674 | 8,574.00% | 1.00 |
| Jul 31, 2026 | 100 | -96.46% | 1.00 |
| Jul 15, 2026 | 2,826 | 100.00% | 1.00 |
| Dec 31, 2025 | 1,949 | 0.00% | 1.00 |
| Dec 15, 2025 | 1,949 | 0.00% | 1.00 |
| Nov 28, 2025 | 1,949 | 0.00% | 1.37 |
| Nov 14, 2025 | 1,949 | 0.00% | 1.00 |
| Oct 31, 2025 | 1,949 | 100.00% | 1.00 |
| May 30, 2025 | 497 | -82.73% | 1.00 |
| May 15, 2025 | 2,878 | -38.12% | 1.00 |
| Apr 30, 2025 | 4,651 | -82.35% | 1.00 |
| Apr 15, 2025 | 26,351 | 314.91% | 1.56 |
Full history, charts, and borrow-fee detail are on the RMTG short interest page.
Frequently asked questions
What is the current short interest in RMTG?
As of the latest FINRA settlement dated August 14, 2026, RMTG had approximately 8,674 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short RMTG?
The latest borrow fee (cost to borrow) for RMTG is 17.87% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for RMTG?
Days to cover for RMTG is approximately 0.09 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is RMTG a short squeeze candidate?
A squeeze needs shorts that are hard to close. RMTG trades about 98,002 shares a day and would take roughly 0.09 days to unwind current short positions, at a current borrow fee of 17.87%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.